Abstract

As part of their description of an outbreak of vancomycin, now more usually termed glycopeptide, resistant enterococci (GRE) in a Dutch hospital published in last week’s British Medical Journal, Ridwan and colleagues explore what should be done to prevent spread in European hospitals (1).